De-escalating breast cancer therapy; can some patients be spared chemotherapy?
About one of every five breast cancers presents with high levels of HER2 proteins. Known…
Browsing: Genetics
New research gives hope in the fight against pancreatic cancer
Mariano Barbacid, Centro Nacional de Investigaciones Oncológicas CNIO Pancreatic ductal adenocarcinoma (PDAC), the most common…
New study highlights need for ethnic and ancestral diversity in genomic research
A new multicenter analysis led by researchers at the Fred Hutchinson Cancer Research Center, the…
New biomarker test improves diagnosis of ovarian cancer
The majority of women who undergo surgery for suspected ovarian cancer do not have cancer.…
Canadian researchers discover new genetic link to premenopausal breast cancer
University of Alberta researchers have added a new genetic marker to the breast cancer map,…
EHA 2019: Genomic evidence of residual disease in patients in remission prior to stem cell transplant; fate or opportunity for early intervention?
Acute myeloid leukaemia (AML) is a rare, highly fatal blood cancer. Allogeneic haematopoietic cell transplantation…
EHA 2019: Burning out the T-ALL engine: NADK is a new therapeutic target in T-cell Acute Lymphoblastic Leukaemia
T-cell acute lymphoblastic leukaemia (T-ALL) is an aggressive cancer which is lethal to 15% of…
ASCO 2019: Cleveland researchers test novel gene therapy for glioblastoma
A novel gene therapy clinical trial at University Hospitals Seidman Cancer Center and the Case…
ASCO 2019: Maintenance therapy with PARP inhibitor olaparib delays progression of BRCA-related pancreatic cancer
The randomised, phase III POLO trial found that maintenance therapy with the PARP inhibitor olaparib…
Pancreatic cancer specialist explains challenges of the disease and treatment advances
Nathan Bahary, University of Pittsburgh With Alex Trebek’s recent announcement that his pancreatic cancer is…